Login / Signup

Successful treatment with guanfacine in a long-COVID case manifesting marked cognitive impairment.

Tsuyoshi KondoRiki HigaMariko KunibaHotaka ShinzatoYoshikazu Takaesu
Published in: Neuropsychopharmacology reports (2024)
GXR may be helpful in improving subjective/objective cognitive functioning and frontotemporal brain activity in long-COVID patients manifesting apparent cognitive impairment.
Keyphrases
  • cognitive impairment
  • sars cov
  • coronavirus disease
  • respiratory syndrome coronavirus
  • diffusion weighted imaging
  • computed tomography
  • magnetic resonance